RIL
VIR icon

Rothschild Investment LLC’s Vir Biotechnology VIR Stock Holding History

Rothschild Investment LLC’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.43K Buy
+271
New +$2.16K ﹤0.01% 2460
2025
Q2 		– Sell
-160
Closed -$1.04K – 3198
2025
Q1 		$1.04K Buy
160
+40
+33% +$356 ﹤0.01% 2320
2024
Q4 		$881 Buy
120
+40
+50% +$316 ﹤0.01% 2285
2024
Q3 		$599 Buy
80
+20
+33% +$174 ﹤0.01% 2418
2024
Q2 		$534 Buy
60
+50
+500% +$479 ﹤0.01% 1970
2024
Q1 		$101 Buy
+10
New +$102 ﹤0.01% 2209
2023
Q3 		– Sell
-24,850
Closed -$610K – 497
2023
Q2 		$610K Sell
24,850
-3,400
-12% -$85.4K 0.05% 276
2023
Q1 		$657K Sell
28,250
-300
-1% -$7.67K 0.06% 266
2022
Q4 		$723K Sell
28,550
-5,100
-15% -$125K 0.07% 245
2022
Q3 		$649K Sell
33,650
-1,500
-4% -$38.1K 0.06% 251
2022
Q2 		$895K Sell
35,150
-2,100
-6% -$49K 0.08% 225
2022
Q1 		$958K Sell
37,250
-1,300
-3% -$38.6K 0.08% 234
2021
Q4 		$1.61M Hold
38,550
– – 0.13% 161
2021
Q3 		$1.68M Sell
38,550
-2,000
-5% -$86.6K 0.14% 153
2021
Q2 		$1.92M Sell
40,550
-900
-2% -$40.9K 0.15% 141
2021
Q1 		$2.13M Buy
41,450
+18,550
+81% +$1,000K 0.18% 123
2020
Q4 		$613K Buy
22,900
+10,150
+80% +$330K 0.06% 257
2020
Q3 		$438K Buy
+12,750
New +$549K 0.05% 278

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Rothschild Investment LLC's VIR Position: Q1 2026 in Review

Rothschild Investment LLC opened a new position in Vir Biotechnology (VIR) in Q1 2026: 271 shares worth $2.43K. The stake represents ﹤0.01% of the portfolio and ranks #2460 among its holdings. This is a return to the name: Rothschild Investment LLC previously reported a position in VIR as recently as Q1 2025.

Rothschild Investment LLC first reported a position in VIR in Q3 2020 and has held it in 18 quarters since. The position peaked at $2.13M in Q1 2021. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Rothschild Investment LLC held 271 shares of Vir Biotechnology worth $2.43K as of Q1 2026.
  • Vir Biotechnology was a new Rothschild Investment LLC position in Q1 2026.
  • Vir Biotechnology made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2460 holding.
  • Rothschild Investment LLC first reported a position in Vir Biotechnology in Q3 2020 and has held it in 18 quarters since.
  • Rothschild Investment LLC's Vir Biotechnology position peaked at $2.13M in Q1 2021.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.